Hot topics in genitourinary cancers: A multidisciplinary discussion on state-of-the-art and latest developments among international experts and patient advocacy.

Genitourinary oncology patient advocacy prostate cancer rare genitourinary cancers renal carcinoma urothelial carcinoma

Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
06 Oct 2024
Historique:
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 7 10 2024
Statut: aheadofprint

Résumé

Genitourinary cancers present significant challenges to oncologists, necessitating innovative approaches for improved patient outcomes. The 'Controversies in Genitourinary Cancers' congress, held in January 2024, convened international experts to address the complexities of prostate, bladder, renal and rare genitourinary cancers. Sessions explored current trends, novel treatments, and unmet needs, emphasizing collaborative efforts to advance knowledge and patient care. Through multidisciplinary engagement and patient advocacy, the congress underscored the imperative of collective action in navigating the complexities of genitourinary cancers, ultimately aiming to transform clinical practice and improve patient outcomes.

Identifiants

pubmed: 39370628
doi: 10.1177/03008916241270093
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

3008916241270093

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Alessandro Rametta (A)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Paolo Ambrosini (P)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Chiara Cavalli (C)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Eleonora Gusmaroli (E)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Melanie Claps (M)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Patrizia Giannatempo (P)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Valentina Guadalupi (V)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Marco Stellato (M)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Elena Verzoni (E)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Filippo Maria Guglielmo De Braud (FMG)

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Università di Milano, Milan, Italy.

Giuseppe Procopio (G)

Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Classifications MeSH